Equity Bridge Consulting

Welcome to

Medical Affairs

Equity Bridge Consulting is the only Medical Affairs company that leverages the expertise of medical professionals and academic experts along with established community partnerships specific to bridging the diversity gap in clinical research.

About Us

Our Services

Our Partners

Talks and Appearances

About Us

Our Approach to Medical Affairs

Learn more about The EBC Way, our three-tiered path towards FDORA compliance.

Our Mission and Vision

We’re out to change the world. Here’s how.

Reaching People Across the Globe

Equity Bridge Consulting is best positioned to help our partners achieve their global strategic goals.

Our Leadership

Meet our Founder and President.

Ready to get started or lean more? Let’s start a conversation.

About Us

Our Vision

Our vision is to create a healthier world for everyone.

Our Mission

Equity Bridge Consulting provides scientific support to pharmaceutical, biotechnology, diagnostics, or other medical affairs providers to increase the inclusion of populations that have historically been un- or underrepresented in research and clinical trials. In doing so, we promise to always adhere to our core values of respect, transparency, honesty, research integrity, and inclusion. We do so in a manner that respects the historical context of such work and ultimately benefits our partners, these communities, and all other stakeholders involved.

Our Leadership

Adalynn E. Harris, PhD, MPH, MHA

Founder and President

Dr. Harris is a scientist, educator, and public health proponent who has been committed to health equity and community engagement for over 25 years. Throughout her fifteen year career in the medical affairs division of the pharmaceutical industry, where she specialized in oncology and rare disease clinical trials, Dr. Harris has co-authored research articles and offered presentations to fellow professionals about emerging therapies, health disparities, and current scientific research. Dr. Harris is a proponent for representation of minority, underrepresented, and disenfranchised groups in clinical trials and public health policy and organizes discussions, collaborations, and dissemination of medical information to key stakeholders, including principal investigators, advisory boards, physicians, nurses, pharmacists, and peers in the pharmaceutical industry. Through Equity Bridge Consulting, Dr. Harris remains dedicated to opening opportunities for the advancement of medical knowledge and practices, specifically for minority communities within the US, persons in sub-Saharan Africa, and those from the African diaspora worldwide.

Ph.D. in Biomedical Sciences, Morehouse School of Medicine
Post - Doctoral Research: Winship Cancer Institute, Emory University
Post - Doctoral Research: Neuroscience Institute, Morehouse School of Medicine
Post-Doctoral Fellowship: Fellowship In Research and Science Teaching (FIRST) Emory University
Master of Public Health, UNC-Chapel Hill
Master of Health Administration, George Washington University
BS in Biology, North Carolina A&T State University
Career Experience: Medical Affairs Experience: 15+ years in the pharmaceutical industry - Clinical Trial/Scientific Support; Health Disparities; Strategy Design and Implementation; Advisory Board Facilitation
Academic positions: Adjunct Professor at NC A&T State University, Georgia Perimeter, and Guilford Technical Community Collège

The Problem

Racial and ethnic minorities are sorely unrepresented in clinical trials.

85% of the World’s Population

Are people of people of Indigenous, African, Asian, or Latin American descent, yet they only make up less than 20% of clinical trial participants.

Less than 3%

Of cancer (2.8%) and cardiovascular (2.5%) clinical trial participants are African Americans, even though these Americans have the highest mortality rate related to these diseases.

5.6 Million People

Over 65 years of age have Alzheimer’s disease/other dementias and older African Americans are twice as likely to have it versus older whites.

Only 2.5%

Percent of clinical trials include participants in Africa yet Africa has 25% of the world’s disease burden.

Our Solution

The Equity Bridge Consulting Approach leverages published data from evidenced based research to increase clinical trial diversity. Our Approach focuses on three areas to garnish impactful change.

Increase industry bandwidth to provide efficient medical affairs expertise

Medical Community and Patient Advocacy Education to overcome barriers to participation

Healthcare Workforce Diversification to build an accessible pipeline of medical professionals

Reaching people across the globe

In today’s medical affairs' landscape, the ability to reach populations that are representative of the planet is paramount for success. From the United States to the Carribean to Sub-Saharan Africa and other parts of the world, Equity Bridge Consulting is best positioned to help our partners achieve their global strategic goals.

Ready to Learn More?

Let’s Start a Conversation!